Pulmonary drug toxicity: Radiologic and pathologic manifestations

Radiographics

Volumn 20, Issue 5, 2000, Pages 1245-1259

  Rossi, Santiago E ^a,b   Erasmus, Jeremy J ^a   McAdams, H Page ^a   Sporn, Thomas A ^a   Goodman, Philip C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Fundacion Dr Enrique Rossi   (Argentina)

Author keywords

Drugs, toxidty, 60.64; Lung, diseases, 60.21, 60.64; Lung, effects of drugs on, 60.64; Lung, hemorrhage, 60.4123

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; IMMUNOSUPPRESSIVE AGENT;

CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; HUMAN; LUNG; LUNG DISEASE; PATHOLOGY; RADIOGRAPHY; REVIEW;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034264117     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.20.5.g00se081245     Document Type: Article

References (33)

1. Cooper JA Jr. Drug-induced lung disease. Adv Intern Med 1997; 42:231-268.
2. Meyers JL. Pathology of drug-induced lung disease. In: Katzenstein AA, Askin FB, eds. Katzenstein and Askin's surgical pathology of non-neoplastic lung disease. 3rd ed. Philadelphia, Pa: Saunders, 1997; 4:81-111.
3. Pietra GG. Pathologic mechanisms of drug-induced lung disorders. J Thorac Imaging 1991; 6: 1-7.
4. Kay JM. Drug-induced lung disease. In: Hasleton PS, ed. Spencer's pathology of the lung. 5th ed. New York, NY: McGraw-Hill, 1996; 551-595.
5. Smith GJ. The histopathology of pulmonary reactions to drugs. Clin Chest Med 1990; 11:95-117.
6. Kuhlman JE, Teigen C, Ren H, Hurban RH, Hutchins GM, Fishman EK. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 1990; 177:121-125.
7. Holoye P, Jenkins D, Greensberg S. Pulmonary toxicity in long-term administration of BCNU. Cancer Treat Rep 1976; 60:1691-1694.
8. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. 1. Cytotoxic drugs. Am Rev Resp Dis 1986; 133:321-340.
9. Kennedy J, Myers J, Plumb V, Fulmer J. Amiodarone pulmonary toxicity: clinical, radiologic, and pathologic correlations. Arch Intern Med 1987; 147:50-55.
10. McAdams HP, Rosado-de-Christenson ML, Wehunt WD, Fishback NF. The alphabet soup revisited: the chronic interstitial pneumonias in the 1990s. RadioGraphics 1996; 16:1009-1033.
11. Rosenow EC, Myers JL, Swensen SJ, Pisani RJ. Drug-induced pulmonary disease: an update. Chest 1992; 102:239-250.
12. Epler GR, Colby TV, McLoud TC, Carington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312:152-158.
13. Boggess KA, Benedetti TJ, Raghu G. Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature. Obstet Gynecol Surv 1996; 51:367-370.
14. Ginsberg S, Comis R. The pulmonary toxicity of antineoplastic agents. Semin Oncol 1982; 9:34-51.
15. Sostman H, Matthay R, Putman C, Smith G. Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976; 55:371-388.
16. Malik SW, Myers JL, De Remee RA, Specks U. Lung toxicity associated with cyclophosphamide use: two distinct patterns. Am J Respir Grit Care Med 1996; 154:1851-1856.
17. Burke D, Stoddart J, Ward M, Simpson C. Fatal pulmonary fibrosis occurring during treatment with cyclophosphamide. Br Med J (Clin Res Ed) 1982; 285:696.
18. Spector J, Zimbler H, Ross J. Early-onset cyclophosphamide-induced interstitial pneumonitis. JAMA 1979; 242:2852-2854.
19. Aronin P, Mahaley M, Rudnick S. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors. N Engl J Med 1980; 303:183-188.
20. Litam J, Dail D, Spitzer G. Early pulmonary toxicity after administration of high-dose BCNU. Cancer Treat Rep 1981; 65:39-44.
21. Iacovino J, Leitner J, Abbas A. Fatal pulmonary reaction from low doses of bleomycin: an idiosyn-cratic tissue response. JAMA 1976; 235:1253-1255.
22. Rosenow EC III. Drug-induced pulmonary disease. Dis Mon 1994; 15:255-310.
23. Aronchick JM, Gefter WB. Drug-induced pulmonary disorders. Semin Roentgenol 1995; 30:18-34.
24. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. 2. Noncytotoxic drugs. Am Rev Resp Dis 1986; 133:488-505.
25. Praire AE, Guntupalli KK, Greenberg SD, Cartwright J Jr, Chasen MH. Amiodarone pulmonary toxicity: a multidisciplinary review of current status. South Med J 1993; 86:67-77.
26. Chai JL, Patz EF Jr. CT of the lung: patterns of calcification and other high-attenuation abnormalities. AJR Am J Roentgenol 1994; 162:1063-1066.
27. Scott DL, Bradby GV, Aitman TJ, Zaphiropoulos GC, Hawkins CF. Relationship of gold and penicillamine therapy to diffuse interstitial lung disease. Ann Rheum Dis 1981;40:136-141.
28. Evens CS, Wescott JL, Bragg DG. Methotrexate therapy and pulmonary disease. Radiology 1973; 107:539-543.
29. Cannon GW. Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 1997; 23:917-937.
30. Padley SP, Adler B, Hansell DM, Müller NL. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46:232-236.
31. Morrison DA, Goldman AL. Radiologic patterns of drug-induced lung disease. Radiology 1979; 131: 299-304.
32. Ramanathan RK, Reddy VV, Holbert JM, Belani CP. Pulmonary infiltrates following administration of paclitaxel. Chest 1996; 110:289-292.
33. Eisenhauer EA, Vermorken JB. The taxoids: comparative clinical pharmacology and therapeutic potential. Drugs 1998; 55:5-30.